HLA-E and B-cell chronic lymphocytic leukemia: However, there is already evidence that the HLA-E∗01:03 allele is an independent predictor of the early treatment needs of CLL patients [17], which proves the polymorphism of the HLA-E gene, as a disease marker, plays an important role in the occurrence and development of leukemia.